Literature DB >> 31313103

Facilitating Informed Permission/Assent/Consent in Pediatric Clinical Trials.

Susan M Abdel-Rahman1,2.   

Abstract

Individuals approached to participate in human subjects research, irrespective of age, must be completely apprised of the study, and researchers must ensure that the information is understood to the fullest extent possible, prior to decision making. However, evolving regulatory and institutional requirements have led to permission/assent/consent (PAC) forms that are unnecessarily complex, serving only to exacerbate the challenges associated with communicating this important information to prospective participants. At greatest risk are children and other individuals with low literacy, limited English proficiency, and diminished mental capacity, populations all too often neglected in clinical research. This paper examines various strategies that have been evaluated to facilitate informed PAC, drawing on experiences across a broad array of populations whose needs overlap with those of children. These strategies range from simplifying PAC forms for readability and creating multimedia PAC delivery tools to actively engaging participants on their understanding of PAC elements by leveraging testing, rewards, and third-party communications. Notably, the findings from strategies that have been explored in more than one setting are uniformly mixed with respect to their ability to improve comprehension, underscoring the challenges that persist in designing, implementing, and objectively examining strategies intended to facilitate informed PAC. However, these studies do serve to highlight efforts that may reduce anxiety around, and increase the satisfaction of participants with, the PAC process. Ultimately, accommodating a diverse participant pool will require the consideration, and continual refinement, of various PAC strategies along with the engagement of team members who are intimately familiar with these populations.

Entities:  

Mesh:

Year:  2019        PMID: 31313103     DOI: 10.1007/s40272-019-00347-5

Source DB:  PubMed          Journal:  Paediatr Drugs        ISSN: 1174-5878            Impact factor:   3.022


  98 in total

1.  A new readability yardstick.

Authors:  R FLESCH
Journal:  J Appl Psychol       Date:  1948-06

2.  Analysis of the compliance of informed consent documents with good clinical practice guideline.

Authors:  Biswa M Padhy; Pooja Gupta; Yogendra K Gupta
Journal:  Contemp Clin Trials       Date:  2011-06-02       Impact factor: 2.226

3.  Written informed consent in patients with breast cancer.

Authors:  H B Muss; D R White; R Michielutte; F Richards; M R Cooper; S Williams; J J Stuart; C L Spurr
Journal:  Cancer       Date:  1979-04       Impact factor: 6.860

4.  Effectiveness of two methods for informing schizophrenic patients about neuroleptic medication.

Authors:  I Kleinman; D Schachter; J Jeffries; P Goldhamer
Journal:  Hosp Community Psychiatry       Date:  1993-12

5.  Informed consent, memory and age.

Authors:  H A Taub
Journal:  Gerontologist       Date:  1980-12

6.  Quality of informed consent in cancer clinical trials: a cross-sectional survey.

Authors:  S Joffe; E F Cook; P D Cleary; J W Clark; J C Weeks
Journal:  Lancet       Date:  2001-11-24       Impact factor: 79.321

Review 7.  Communication and informed consent in phase 1 trials: a review of the literature from January 2005 to July 2009.

Authors:  Valerie A Jenkins; John L Anderson; Lesley J Fallowfield
Journal:  Support Care Cancer       Date:  2010-03-04       Impact factor: 3.603

8.  How to achieve informed consent for research from Spanish-speaking individuals with low literacy: a qualitative report.

Authors:  Dharma E Cortés; Mari-Lynn Drainoni; Lori E Henault; Michael K Paasche-Orlow
Journal:  J Health Commun       Date:  2010

9.  The effectiveness of patient verbalization on informed consent.

Authors:  V Wadey; C Frank
Journal:  Can J Surg       Date:  1997-04       Impact factor: 2.089

10.  An intervention to improve cancer patients' understanding of early-phase clinical trials.

Authors:  Nancy E Kass; Jeremy Sugarman; Amy M Medley; Linda A Fogarty; Holly A Taylor; Christopher K Daugherty; Mark R Emerson; Steven N Goodman; Fay J Hlubocky; Herbert I Hurwitz; Michael Carducci; Annallys Goodwin-Landher
Journal:  IRB       Date:  2009 May-Jun
View more
  2 in total

1.  Level of education and preferred language of informed consent for clinical research in a multi-lingual community.

Authors:  Grace Muzanyi; Isaac Sekitoleko; John L Johnson; Jane Lunkuse; Gladys Nalugwa; Joanita Nassali; David Kaawa Mafigiri
Journal:  Afr Health Sci       Date:  2020-06       Impact factor: 0.927

2.  Consent Builder: an innovative tool for creating research informed consent documents.

Authors:  Katherine A Sward; Rene Enriquez; Jeri Burr; Julie Ozier; Megan Roebuck; Carrie Elliott; J Michael Dean
Journal:  JAMIA Open       Date:  2022-07-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.